Health Catalyst downgraded at Wells Fargo after Q4 results
Source: SeekingAlpha
2026-03-18 13:52:26 ET
More on Health Catalyst
- Health Catalyst, Inc. (HCAT) Q4 2025 Earnings Call Transcript
- Health Catalyst plummets after mixed Q4; CEO declines to rule out potential sale as part of review
- Health Catalyst refrains from 2026 annual guidance as new CEO launches operational overhaul and strategic review
- Seeking Alpha’s Quant Rating on Health Catalyst
- Historical earnings data for Health Catalyst
Read the full article on Seeking Alpha
For further details see:
Health Catalyst downgraded at Wells Fargo after Q4 results
Health Catalyst Inc
NASDAQ: HCAT
HCAT Trading
40.86% G/L:
$1.81 Last:
21,651,833 Volume:
$1.78 Open:
HCAT Latest News
June 04, 2026 10:06:00 am
Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield
June 04, 2026 09:03:29 am
Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation
HCAT Stock Data
$146,412,930
68,891,881
0.25%
50
N/A
Healthcare Providers & Services
Healthcare
US
South Jordan
